Shandong Wohua Pharmaceutical Co., Ltd. (002107) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shandong Wohua Pharmaceutical Co., Ltd.

Why is Shandong Wohua Pharmaceutical Co., Ltd. ?

With a growth in Net Profit of 64.2%, the company declared Very Positive results in Dec 25

ROCE(HY) Highest at 13.47%
DEBTORS TURNOVER RATIO(HY) Highest at 9.84 times
INTEREST COVERAGE RATIO(Q) Highest at 347,453.25

With ROE of 8.80%, it has a fair valuation with a 4.84 Price to Book Value

Over the past year, while the stock has generated a return of 25.95%, its profits have risen by 144.8% ; the PEG ratio of the company is 0.4

Market Beating Performance

The stock has generated a return of 25.95% in the last 1 year, much higher than market (China Shanghai Composite) returns of 13.33%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Shandong Wohua Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shandong Wohua Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Shandong Wohua Pharmaceutical Co., Ltd.

30.8%

1.06

43.27%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.25%

EBIT Growth (5y)

-14.62%

EBIT to Interest (avg)

56.40

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

1.11

Tax Ratio

18.74%

Dividend Payout Ratio

160.43%

Pledged Shares

Institutional Holding

ROCE (avg)

24.88%

ROE (avg)

12.98%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.84

EV to EBIT

47.06

EV to EBITDA

32.03

EV to Capital Employed

10.09

EV to Sales

4.05

PEG Ratio

0.38

Dividend Yield

1.93%

ROCE (Latest)

21.44%

ROE (Latest)

8.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company

ROCE(HY)

Highest at 13.47%

DEBTORS TURNOVER RATIO(HY)

Highest at 9.84 times

INTEREST COVERAGE RATIO(Q)

Highest at 347,453.25

RAW MATERIAL COST(Y)

Fallen by -4.71% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.08 times

OPERATING PROFIT(Q)

Highest at CNY 38.93 MM

OPERATING PROFIT MARGIN(Q)

Highest at 20.24 %

PRE-TAX PROFIT(Q)

Highest at CNY 33.9 MM

NET PROFIT(Q)

Highest at CNY 31.72 MM

EPS(Q)

Highest at CNY 0.06

-8What is not working for the Company

INTEREST(HY)

At CNY 0.03 MM has Grown at 152.59%

Here's what is working for Shandong Wohua Pharmaceutical Co., Ltd.

Interest Coverage Ratio

Highest at 347,453.25

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Debtors Turnover Ratio

Highest at 9.84 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit

Highest at CNY 38.93 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 20.24 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 33.9 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 33.9 MM has Grown at 57.72%

over average net sales of the previous four periods of CNY 21.49 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 31.72 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 31.72 MM has Grown at 63.74%

over average net sales of the previous four periods of CNY 19.37 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 2.08 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -4.71% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shandong Wohua Pharmaceutical Co., Ltd.

Interest

At CNY 0.03 MM has Grown at 152.59%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)